Clinical Studies: 2004 Start Date

Basal Cell Carcinoma
Sponsor: Genentech, Inc.
A Phase I, Double-Blind, Randomized, Placebo Controlled, Multicenter Study Evaluating the Safety and Tolerability of a Multidose Regimen of XXXXX Topically Applied to Superficial or Nodular Basal Cell Carcinoma.
June 2004 to July 2006

Psoriasis
Sponsor: Genentech, Inc.
XXXXX Epidemiologic Study of Psoriasis Outcomes and Safety Events  RESPONSE) in Patients with Chronic Moderate to Severe Plaque Psoriasis.
April 2004 to Present

Psoriasis
Sponsor: Abbott Laboratories
A Phase III, Multicenter Study of the Efficacy and Safety of Long-Term XXXXX Treatment in Subjects with Moderate to Severe Chronic Plaque Psoriasis.
October 2004 to December 2005

Actinic Keratosis
Sponsor: 3M
A Phase IIIb, Open-Label Effectiveness and Safety Study of XXXXX in the Treatment of Actinic Keratosis.
April 2004 to August 2004

Psoriasis
Sponsor: Centocor, Inc.
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of XXXXX Induction Therapy Followed by Multiple Regiments of Maintenance XXXXX Therapy in Subjects with Plaque-Type Psoriasis
February 2004 to June 2005

Psoriasis
Sponsor: Amgen, Inc.
A Multicenter, Open-Label, Prospective Study to Evaluate the Safety of Patients with XXXXX.
March 2004 to November 2004

Psoriasis
Sponsor: Fujisawa Healthcare, Inc.
A Phase III, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Once Daily 0.3% XXXXX Gel Versus Gel Vehicle in the Treatment of Psoriasis.
March 2004 to November 2004

Clinical Studies